Preventive Medicine and Environmental Health, Osaka City University Graduate School of Medicine.
Hematology, Osaka City University Graduate School of Medicine.
J Epidemiol. 2018 Aug 5;28(8):361-366. doi: 10.2188/jea.JE20170082. Epub 2018 Apr 7.
Metabolically healthy obesity seems to be a unique phenotype for the risk of cardiometabolic diseases. However, it is not known whether this phenotype is associated with the risk of proteinuria.
Study subjects were 9,185 non-diabetic Japanese male workers aged 40-55 years who had no proteinuria, an estimated glomerular filtration rate ≥60 mL/min/1.73 m, no history of cancer, and no use of antihypertensive or lipid-lowering medications at baseline. Obesity was defined as body mass index ≥25.0 kg/m. Metabolic health was defined as the presence of no Adult Treatment Panel III components of the metabolic syndrome criteria, excluding waist circumference, and metabolic unhealth was defined as the presence of one or more metabolic syndrome components, excluding waist circumference. "Consecutive proteinuria" was considered positive if proteinuria was detected twice consecutively as 1+ or higher on urine dipstick at annual examinations to exclude chance proteinuria as much as possible.
During the 81,660 person-years follow-up period, we confirmed 390 cases of consecutive proteinuria. Compared with metabolically healthy non-obesity, metabolically healthy obesity was not associated with the risk of consecutive proteinuria (multiple-adjusted hazard ratio [HR] 0.86; 95% confidence interval [CI], 0.37-1.99), but metabolically unhealthy non-obesity with ≥2 metabolic syndrome components (HR 1.77; 95% CI, 1.30-2.42), metabolically unhealthy obesity with one component (HR 1.71; 95% CI, 1.12-2.61), and metabolically unhealthy obesity with ≥2 metabolic syndrome components (HR 2.77; 95% CI, 2.01-3.82) were associated with an increased risk of consecutive proteinuria.
Metabolically healthy obesity did not increase the risk of consecutive proteinuria in Japanese middle-aged men.
代谢健康型肥胖似乎是一种独特的表型,与心血管代谢疾病的风险相关。然而,目前尚不清楚这种表型是否与蛋白尿风险相关。
研究对象为 9185 名非糖尿病的日本男性工人,年龄在 40-55 岁之间,基线时无蛋白尿、估计肾小球滤过率≥60 mL/min/1.73 m²、无癌症史且未使用降压或降脂药物。肥胖定义为体质指数≥25.0 kg/m²。代谢健康定义为不存在美国成人治疗指南 III 代谢综合征标准的组分,不包括腰围;代谢不健康定义为存在一个或多个代谢综合征组分,不包括腰围。“连续蛋白尿”定义为在年度体检中,两次连续尿蛋白试纸检测为 1+或更高,以尽可能排除偶然蛋白尿。
在 81660 人年的随访期间,我们确诊了 390 例连续蛋白尿病例。与代谢健康非肥胖相比,代谢健康型肥胖与连续蛋白尿风险无关(多因素调整后的风险比 [HR] 0.86;95%置信区间 [CI],0.37-1.99),但代谢不健康非肥胖且有≥2 个代谢综合征组分(HR 1.77;95% CI,1.30-2.42)、代谢不健康肥胖且有 1 个组分(HR 1.71;95% CI,1.12-2.61)、代谢不健康肥胖且有≥2 个代谢综合征组分(HR 2.77;95% CI,2.01-3.82)与连续蛋白尿风险增加相关。
在日本中年男性中,代谢健康型肥胖不会增加连续蛋白尿的风险。